Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	159.49	75.62	-	-	-	-
Cost of Revenue	112.86	112.86	103.37	-	-	-
Gross Profit	46.62	-37.24	-103.37	-	-	-
Selling, General & Admin	43.56	43.87	39.94	35.12	15.73	4.01
Research & Development	5.2	-	-	77.26	57.16	24.01
Operating Expenses	48.75	43.87	39.94	112.38	72.88	28.01
Operating Income	-2.13	-81.11	-143.31	-112.38	-72.88	-28.01
Interest & Investment Income	11.56	10.57	9.33	3.76	0.05	0.01
Currency Exchange Gain (Loss)	-0.03	0.42	-0.93	0.01	-0.16	-0.2
Other Non Operating Income (Expenses)	-	-	-	-	-0.96	-7.68
EBT Excluding Unusual Items	9.4	-70.13	-134.91	-108.61	-73.96	-35.88
Gain (Loss) on Sale of Investments	-	-	-0.13	-	-	-
Gain (Loss) on Sale of Assets	0.06	-	0.02	0.11	-	-
Pretax Income	9.46	-70.13	-135.01	-108.5	-73.96	-35.88
Income Tax Expense	3.31	2.57	0.34	-	-	-
Net Income	6.15	-72.7	-135.35	-108.5	-73.96	-35.88
Net Income to Common	6.15	-72.7	-135.35	-108.5	-73.96	-35.88
Shares Outstanding (Basic)	79	74	51	47	25	2
Shares Outstanding (Diluted)	80	74	51	47	25	2
Shares Change (YoY)	47.16%	43.80%	8.83%	88.91%	1548.09%	7.11%
EPS (Basic)	0.08	-0.98	-2.63	-2.30	-2.96	-23.65
EPS (Diluted)	0.08	-0.98	-2.63	-2.30	-2.96	-23.65
Free Cash Flow	30.48	38.01	-62.84	-105.38	-69.1	-26.44
Free Cash Flow Per Share	0.38	0.51	-1.22	-2.23	-2.76	-17.43
Gross Margin	29.23%	-49.25%	-	-	-	-
Operating Margin	-1.33%	-107.26%	-	-	-	-
Profit Margin	3.86%	-96.14%	-	-	-	-
Free Cash Flow Margin	19.11%	50.26%	-	-	-	-
EBITDA	6.14	-72.99	-137.09	-108.64	-70.75	-27.47
EBITDA Margin	3.85%	-96.52%	-	-	-	-
D&A For EBITDA	8.27	8.12	6.22	3.75	2.13	0.54
EBIT	-2.13	-81.11	-143.31	-112.38	-72.88	-28.01
EBIT Margin	-1.33%	-107.26%	-	-	-	-

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q